Evidence map›Paper›PMID 39207053›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Sphingosine Kinase 2 Regulates Aryl Hydrocarbon Receptor Nuclear Translocation and Target Gene Activation.

Shigetoshi Yokoyama, Imhoi Koo, Daisuke Aibara, Yuan Tian, Iain A Murray, Stephanie L Collins, Denise M Coslo, Mari Kono, Jeffrey M Peters, Richard L Proia and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shigetoshi YokoyamaDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Imhoi KooDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Daisuke AibaraCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Yuan TianDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Iain A MurrayDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Stephanie L CollinsDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802, USA.
Denise M CosloDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Mari KonoGenetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Jeffrey M PetersDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Richard L ProiaGenetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Frank J GonzalezCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Gary H PerdewDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
Andrew D PattersonDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, 16802, USA.ORCID 0000-0003-2073-0070

Funding

Activation of the Ah receptor and epithelial integrityR35ES028244 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PERDEW, GARY H. · 2017 to 2024
$6.2M
Environmental Chemical Impact on the Host-Microbiome InteractionR35ES035027 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Andrew Patterson · 2023 to 2026
$3.6M
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic AxisR01ES028288 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PATTERSON, ANDREW · 2017 to 2021
$1.7M
Acquisition of an Orbitrap Fusion Lumos Tribid Mass Spectrometer to Accelerate Metabolite Identification and Pathway AnalysisS10OD021750 · OD · PENNSYLVANIA STATE UNIVERSITY, THE · PI PATTERSON, ANDREW · 2017 to 2017
$966k
Fukuoka Public Health Promotion Organization Cancer Research Fund 21K15424Intramural Research Program, National Cancer Institute, Cencer for Cancer Research, Cancer Innovation LaboratoryNational Institute of Food and Agriculture PEN4917#7006412NIEHS NIH HHS ES028244NIEHS NIH HHS ES028288NIEHS NIH HHS ES035027NIEHS NIH HHS R01 ES028288NIEHS NIH HHS R35 ES028244NIEHS NIH HHS R35 ES035027NIH HHS S10 OD021750NIH Office of the Director S10OD021750Science Achievement Graduate Fellowship, Pennsylvania State University
6 · The paper itself

Abstract

Sphingolipids play vital roles in metabolism and regulation. Previously, the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, was reported to directly regulate ceramide synthesis genes by binding to their promoters. Herein, sphingosine kinase 2 (SPHK2), responsible for producing sphingosine-1-phosphate (S1P), was found to interact with AHR through LXXLL motifs, influencing AHR nuclear localization. Through mutagenesis and co-transfection studies, AHR activation and subsequent nuclear translocation was hindered by SPHK2 LXXLL mutants or SPHK2 lacking a nuclear localization signal (NLS). Similarly, an NLS-deficient AHR mutant impaired SPHK2 nuclear translocation. Silencing SPHK2 reduced AHR expression and its target gene CYP1A1, while SPHK2 overexpression enhanced AHR activity. SPHK2 was found enriched on the CYP1A1 promoter, underscoring its role in AHR target gene activation. Additionally, S1P rapidly increased AHR expression at both the mRNA and protein levels and promoted AHR recruitment to the CYP1A1 promoter. Using mouse models, AHR deficiency compromised SPHK2 nuclear translocation, illustrating a critical interaction where SPHK2 facilitates AHR nuclear localization and supports a positive feedback loop between AHR and sphingolipid enzyme activity in the nucleus. These findings highlight a novel function of SPHK2 in regulating AHR activity and gene expression.

Indexed as

Phosphotransferases (Alcohol Group Acceptor)Receptors, Aryl HydrocarbonAnimalsBasic Helix-Loop-Helix ProteinsCell NucleusCytochrome P-450 CYP1A1HumansMicePromoter Regions, GeneticSphingosineSphingosine KinaseBasic Helix-Loop-Helix ProteinsCytochrome P-450 CYP1A1Phosphotransferases (Alcohol Group Acceptor)Receptors, Aryl HydrocarbonSphingosineSphingosine Kinasesphingosine kinase 2, humansphingosine kinase 2, mouseAHRceramidesphingolipidSPHK2

Identifiers

PMID39207053
PMCPMC11516111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.